Zobrazeno 1 - 10
of 83
pro vyhledávání: '"M. A. Zenkova"'
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 2, Pp 188-199 (2024)
INTRODUCTION. The use of cationic liposomes is a promising approach to the delivery of therapeutic nucleic acids to target cells because liposomes can protect nucleic acids from degradation by extracellular nucleases. However, to ensure selective del
Externí odkaz:
https://doaj.org/article/43cf04fb55474591be5c22a513f37ce2
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 2, Pp 140-156 (2024)
INTRODUCTION. The development of malignant neoplasms is associated with changes in the expression of small non-coding RNAs (miRNAs). This emphasises the need for research into the development of miRNA-targeted inhibitors as a promising approach to ca
Externí odkaz:
https://doaj.org/article/6690babde4ae4d89b7cb5b8712c94f88
Publikováno v:
Бюллетень сибирской медицины, Vol 7, Iss 0, Pp 113-118 (2008)
Externí odkaz:
https://doaj.org/article/3a4b202faa694da388bbfeb04c75b2be
Publikováno v:
Biogeosciences, Vol 3, Iss 3, Pp 243-249 (2006)
The nonenzymatic template-directed ligation of oligonucleotides containing 2', 3'-cyclic phosphate was investigated in the presence of divalent cations. Ligation of the oligonucleotides readily occurred in the presence of Mg2+, Mn2+, Co2+, Zn2+, Pb2+
Externí odkaz:
https://doaj.org/article/722f3890855e4f79b97b486be2efafcc
Publikováno v:
Russian Journal of Bioorganic Chemistry. 49:41-51
Publikováno v:
Molecular Biology. 54:233-242
Autor:
P. V. Zelenikhin, I. S. Ead Mohamed, A. I. Nadyrova, A. A. Sirotkina, V. V. Ulyanova, N. L. Mironova, V. A. Mitkevich, A. A. Makarov, M. A. Zenkova, O. N. Ilinskaya
Publikováno v:
Molecular Biology. 54:128-133
Publikováno v:
Molecular Biology. 52:262-268
Publikováno v:
Molecular Biology. 51:562-570
Publikováno v:
Molekuliarnaia biologiia. 54(2)
Melanoma is one of the most aggressive tumors and is accompanied by the induction of local and systemic inflammatory responses. Combinations of chemotherapeutic agents with immunotherapy are therefore commonly used for melanoma treatment. A B16 melan